Ming Zi Chen

Amministratore Delegato presso WuXi Biologics Germany GmbH

54 anni

Consumer Services

Commercial Services

Health Technology

Profilo

Ming Zi Chen is currently the Co-Managing Director at WuXi Biologics Germany GmbH and the Chief Business Officer at InSilico Medicine Cayman TopCo. Chen holds a doctorate degree from the University of Washington.

Posizioni attive di Ming Zi Chen

Società	Posizione	Inizio
WuXi Biologics Germany GmbH WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen.	Amministratore Delegato	-
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Corporate Officer/Principal	01/10/2021

Tutte le posizioni attive di Ming Zi Chen

Formazione di Ming Zi Chen

University of Washington

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ming Zi Chen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Insilico Medicine Cayman TopCo Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.	Commercial Services
WuXi Biologics Germany GmbH WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen.	Health Technology